1 |
于世凤.口腔组织病理学[M]. 7版. 北京: 人民卫生出版社, 2012: 259-261.
|
|
Yu SF. Oral histopathology[M]. 7th ed. Beijing: People's Medical Publishing House, 2012: 259-261.
|
2 |
王新木, 马威, 封兴华. 颌骨嗜酸性肉芽肿临床病理回顾性研究[J]. 口腔医学研究, 2004, 20(2): 201-202.
|
|
Wang XM, Ma W, Feng XH. Retrospective study of clinical pathological of jawbone eosinophilic granuloma[J]. J Oral Sci Res, 2004, 20(2): 201-202.
|
3 |
余问桥, 郑光勇, 梁新华. 颌面部骨嗜酸性肉芽肿18例临床分析[J]. 口腔颌面外科杂志, 2006, 16(4): 333-334, 345.
|
|
Yu WQ, Zheng GY, Liang XH. Clinical analysis of eosinophilic granuloma of bone in maxillofacial region: 18 cases report[J]. Chin J Oral Maxillofac Surg, 2006, 16(4): 333-334, 345.
|
4 |
吕标, 陶谦. 颌骨嗜酸性肉芽肿的临床特点[J]. 国际口腔医学杂志, 2008, 35(2): 201-203.
|
|
Lü B, Tao Q. Clinical features of eosinophilic granuloma of jaw[J]. Int J Stomatol, 2008, 35(2): 201-203.
|
5 |
Raviraj J, Venkata S, Shaik S, et al. Multifocal eosinophilic granuloma of jaws and skull with classical and unusual radiographic/imaging findings[J]. J Clin Diagn Res, 2017, 11(1): ZD9-ZD11.
|
6 |
Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell Histiocytosis[J]. Blood, 2010, 116(11): 1919-1923.
|
7 |
Silvestros SS, Mamalis AA, Sklavounou AD, et al. Eosinophilic granuloma masquerading as aggressive periodontitis[J]. J Periodontol, 2006, 77(5): 917-921.
|
8 |
陶谦, 曾融生, 苏凯, 等. 颌骨嗜酸性肉芽肿的临床特点——文献复习及1例报告[J]. 口腔医学, 2007, 27(10): 516-518.
|
|
Tao Q, Zeng RS, Su K, et al. Clinical characteristics of eosinophilic granuloma of jaws: literature reviews and a case report[J]. Stomatology, 2007, 27(10): 516-518.
|
9 |
dos Anjos Pontual ML, da Silveira MM, de Assis Silva Lima F, et al. Eosinophilic granuloma in the jaws[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104(6): e47-e51.
|
10 |
石利强, 孟庆江, 王艳清, 等. 颌骨嗜酸性肉芽肿临床X线分析[J]. 中国临床医学影像杂志, 2002, 13(3): 224-225.
|
|
Shi LQ, Meng QJ, Wang YQ, et al. X-ray analysis of eosinophilic granuloma of bone in jaws[J]. J China Clin Med Imag, 2002, 13(3): 224-225.
|
11 |
Zhi L, Li ZB, Wei Z, et al. Eosinophilic granuloma of the jaws: an analysis of clinical and radiographic presentation[J]. Oral Oncol, 2006, 42(6): 574-580.
|
12 |
陆东辉, 陈菲, 王铁梅, 等. 15例颌骨嗜酸性肉芽肿的临床与病理研究[J]. 华西口腔医学杂志, 2005, 23(5): 450-451.
|
|
Lu DH, Chen F, Wang TM, et al. Clinical and pathological study of eosinophilic granuloma of the jaw in 15 cases[J]. West China J Stomatol, 2005, 23(5): 450-451.
|
13 |
Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients[J]. Oral Oncol, 2003, 39(7): 687-694.
|
14 |
邵山, 郑家伟, 邵宇, 等. 颌骨嗜酸性粒细胞肉芽肿21例临床分析[J]. 上海口腔医学, 2004, 13(4): 328-330.
|
|
Shao S, Zheng JW, Shao Y, et al. Eosinophilic granuloma of the jaw: an analysis of 21 cases[J]. Shanghai J Stomatol, 2004, 13(4): 328-330.
|
15 |
Histiocytosis syndromes in children. Writing group of the histiocyte society[J]. Lancet, 1987, 1(8526): 208-209.
|
16 |
Asaumi J, Konouchi H, Hisatomi M, et al. Two cases of polyostotic eosinophilic granuloma[J]. Dentomaxillofac Radiol, 2000, 29(6): 382-385.
|
17 |
韩金友, 王旭霞, 张立新. 颌骨嗜酸性肉芽肿(附二例报告)[J]. 临床口腔医学杂志, 1998, 14(4): 251-253.
|
|
Han JY, Wang XX, Zhang LX. Eosinophilic granuloma of jaw (two cases report)[J]. J Clin Stomatol, 1998, 14(4): 251-253.
|
18 |
Berres ML, Lim KP, Peters T, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups[J]. J Exp Med, 2014, 211(4): 669-683.
|
19 |
Watzke IM, Millesi W, Kermer C, et al. Multifocal eosinophilic granuloma of the jaw: long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesions[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2000, 90(3): 317-322.
|
20 |
Whitcher BL, Webb DJ. Treatment of recurrent eosinophilic granuloma of the mandible following radiation the-rapy[J]. J Oral Maxillofac Surg, 1986, 44(7): 565-570.
|
21 |
Bhaskar PB, White CS, Baughman RA. Eosinophilic gra-nuloma of the mandibular condyle. A case report and ma-nagement discussion[J]. Oral Surg Oral Med Oral Pathol, 1993, 76(5): 557-560.
|
22 |
Anwar MA, Murad F, Dawson E, et al. Immunohistoche-mistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and Meta-analysis of current published literature[J]. J Surg Res, 2016, 203(2): 407-415.
|
23 |
Sahm F, Capper D, Preusser M, et al. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis[J]. Blood, 2012, 120(12): e28-e34.
|
24 |
Roden AC, Hu XW, Kip S, et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases[J]. Am J Surg Pathol, 2014, 38(4): 548-551.
|
25 |
Alayed K, Medeiros LJ, Patel KP, et al. BRAF and MA-P2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases[J]. Hum Pathol, 2016, 52: 61-67.
|
26 |
Wei R, Wang ZQ, Li XL, et al. Frequent BRAFV600E mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis[J]. Biomed Rep, 2013, 1(3): 365-368.
|
27 |
程晓烨, 李妍, 周军, 等. 中国人群朗格汉斯组织细胞增生症患者BRAF V600E突变及临床意义[J]. 中国实验血液学杂志, 2015, 23(2): 526-532.
|
|
Cheng XY, Li Y, Zhou J, et al. BRAF V600E mutation in Chinese patients with Langerhans cell histiocytosis and its clinical significance[J]. J Exp Hematol, 2015, 23(2): 526-532.
|
28 |
Berres ML, Lim KP, Peters T, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups[J]. J Exp Med, 2014, 211(4): 669-683.
|
29 |
Méhes G, Irsai G, Bedekovics J, et al. Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry[J]. Am J Surg Pa-thol, 2014, 38(12): 1644-1648.
|
30 |
Hervier B, Haroche J, Arnaud L, et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation[J]. Blood, 2014, 124(7): 1119-1126.
|
31 |
Schilling B, Sondermann W, Zhao F, et al. Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma[J]. Ann Oncol, 2014, 25(3): 747-753.
|
32 |
Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib[J]. N Engl J Med, 2012, 366(8): 707-714.
|
33 |
Gandolfi L, Adamo S, Pileri A, et al. Multisystemic and multiresistant Langerhans cell histiocytosis: a case treated with BRAF inhibitor[J]. J Natl Compr Canc Netw, 2015, 13(6): 715-718.
|
34 |
Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation[J]. Blood, 2013, 121(9): 1495-1500.
|
35 |
Euskirchen P, Haroche J, Emile JF, et al. Complete remission of critical neurohistiocytosis by vemurafenib[J]. Neurol Neuroimmunol Neuroinflamm, 2015, 2(2): e78.
|